Mount Sinai joins $12M investment round for healthcare AI company

New York City-based Icahn School of Medicine at Mount Sinai joined in on a $12.1 million series A financing round for BeeKeeperAI.

Advertisement

BeeKeeperAI helps health systems deploy artificial intelligence tools in a way that keeps data secure. The company will use the financing to expand its flagship EscrowAI platform, according to a June 27 BeeKeeperAI news release.

EscrowAI is a platform built with Microsoft Azure, which is designed to allow medical organizations to conduct HIPAA-compliant research on real data.

“We look forward to deploying EscrowAI to further secure the privacy of Mount Sinai’s data, and our confidence in EscrowAI is evidenced by our investment in BeeKeeperAI. The deployment will streamline collaborations to positively impact health and well-being for patients and society,” Erik Lium, PhD, chief commercial innovation officer at Mount Sinai and president of Mount Sinai Innovation Partners, said in the release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.